Abstract
Background
Pediatric syncope accounts for 1–3% of emergency department (ED) visits. Although most cases are benign, 4% are caused by cardiac disease and 3% by seizures, which carry a risk of sudden death or neurologic injury if missed. Vasovagal syncope accounts for 52–74% of cases and postural orthostatic tachycardia syndrome (POTS) for approximately 13%.
Objective
To provide an emergency-department risk-stratified diagnostic and disposition framework for pediatric syncope.
Key findings
A universal 12-lead electrocardiogram (ECG) identifies nearly all life-threatening cardiac causes of syncope. When combined with structured red-flag screening and clinical risk stratification, patients can be reliably divided into low-, intermediate-, and high-risk groups, allowing safe discharge of benign cases and rapid admission of dangerous ones.
Conclusion
A standardized ED syncope pathway based on risk tiers and ECG-first evaluation improves patient safety while reducing unnecessary admissions and testing.
Clinical trial number
Not applicable.
Keywords: Pediatric syncope, Emergency department, Risk stratification, Electrocardiography, Diagnostic pathway
Introduction
Missed cardiac syncope is one of the most dangerous diagnostic failures in pediatric emergency medicine. Children presenting with transient loss of consciousness may appear well, yet a small subset harbor lethal arrhythmias or structural heart disease that can lead to sudden death if not recognized. The central challenge for the emergency physician is to rapidly identify these high-risk patients while safely discharging the majority with benign etiologies [1].
Pediatric syncope represents 1–3% of ED visits and up to 6% of adolescent hospitalizations [2, 3]. Although most cases are reflex-mediated or orthostatic, approximately 4% are cardiac and 3% neurologic [4]. Because clinical appearance alone is unreliable, emergency department evaluation must be structured, protocol-driven, and anchored by early ECG screening and risk stratification [5, 6].
Mechanisms and evidence-based framework for pediatric syncope in the ED
Pediatric syncope is a common clinical presentation in ED, with incidence peaking during adolescence and recurrence occurring in up to one-third of patients. Despite this high prevalence, fewer than 5% of cases are caused by life-threatening disease [2, 3]. The lifetime cumulative incidence in children and adolescents is estimated to be between 15% and 25% [7]. It has a high recurrence rate and can significantly disrupt daily activities [8]. The peak incidence occurs during adolescence (12–18 years), coinciding with rapid growth and autonomic instability [2, 9]. The purpose of ED evaluation is not to identify the exact mechanism in every child, but to reliably separate dangerous causes from benign ones using a structured, evidence-based framework.
Pathophysiological mechanisms
Reflex (Vasovagal) Syncope (VVS) is the most common mechanism, resulting from an inappropriate autonomic reflex leading to vasodilation and/or bradycardia, which causes transient cerebral hypoperfusion [8, 10]. It is often triggered by orthostatic stress, pain, or emotion and involves the Bezold–Jarisch reflex, characterized by paradoxical vagal activation [11].
Orthostatic Intolerance and Postural Orthostatic Tachycardia Syndrome (POTS) are also common. Orthostatic syncope results from an inadequate autonomic response to standing, leading to venous pooling and reduced venous return [12]. POTS, increasingly recognized in adolescents, is defined by at least 3 months of symptoms of chronic orthostatic intolerance AND a sustained excessive heart rate increase (≥ 40 beats/min in adolescents) within 10 min of standing, in the absence of orthostatic hypotension [13, 14].
Cardiogenic Syncope results from a sudden reduction in cardiac output due to structural or electrical heart disease. Although less common in children, it is the most life-threatening cause.
Arrhythmic causes include long QT syndrome, short QT syndrome, Brugada syndrome, Wolff-Parkinson-White syndrome (WPW), and catecholaminergic polymorphic ventricular tachycardia. While structural causes include hypertrophic cardiomyopathy and coronary artery anomalies, myocarditis is also a cause of syncope/sudden death [15–17]. Syncope during exertion or without a prodrome strongly suggests a cardiac etiology.
Other causes include neurologic conditions that mimic syncope, such as seizures [17], and metabolic disturbances like hypoglycemia [18]. Psychogenic pseudosyncope is an important consideration in adolescents, presenting as an apparent loss of consciousness without true cerebral hypoperfusion [19]. Figure 1 illustrates the clinical classification and risk stratification of pediatric syncope with corresponding red flag categories.
Fig. 1.
Clinical classification and risk stratification of pediatric syncope with corresponding red flag categories
Synthesis of clinical practice guidelines
Several professional bodies have established guidelines for pediatric syncope. A comparison reveals a consensus on initial evaluation but differences in specific recommendations for testing and disposition. Table 1 synthesizes the key recommendations from the American Heart Association/American College of Cardiology (AHA/ACC), the European Society of Cardiology (ESC), and the National Institute for Health and Care Excellence (NICE).
Table 1.
Comparison of major pediatric syncope guidelines: key recommendations, red flag definitions, and disposition criteria across AHA/ACC, ESC, and NICE
| Guidelines Aspect | AHA/ACC Syncope Guidelines [20, 21] | ESC Guidelines [22] | NICE Guidelines [23] |
|---|---|---|---|
| Key Recommendations |
• Evaluation: Universal initial evaluation with history, physical exam, and 12-lead ECG. • Lifestyle & Meds: Lifestyle measures first. Midodrine, salt, and fluid intake may be considered. Fludrocortisone benefit is unclear. • Ineffective Treatments: Beta-blockers are not recommended for pediatric VVS. |
• Evaluation: History and ECG are critical for differentiation. • Diagnosis: Tilt-table testing has limited reliability and should be used cautiously. • Management: Education and reassurance are first-line for benign reflex syncope. Pacemakers are generally avoided. |
• Referral Criteria: Urgent pediatric assessment for all children < 12 years, or for blackouts with seizure markers. • Non-Referral: Children > 12 years with typical VVS features may not require referral if no red flags are present. |
| Red Flag Definitions |
• Syncope during exertion or while supine • Absence of prodrome • Palpitations, chest pain • Abnormal ECG or vital signs • Family history of cardiac disease |
• Family history of sudden cardiac death (< 40 years) • Syncope during exercise or while supine • Syncope without prodrome or with palpitations |
• Not explicitly defined; guidance is based on referral criteria for “blackouts.” |
| Disposition | • Patients with normal vitals and no red flags may be safely discharged with close follow-up. | • Discharge is appropriate when no red flags are identified. | • Not included guidance focuses on referral pathways. |
Abbreviations: AHA/ACC, American Heart Association/American College of Cardiology; ECG, Electrocardiogram; VVS, Vasovagal syncope; ESC, European Society of Cardiology; NICE, National Institute for Health and Care Excellence
Gaps in current practice
Despite these guidelines, significant gaps in care persist. There are no universal standards for the timing and communication of ECG interpretation, and the accuracy of interpretation by non-cardiologists is variable [24]. In the ED, patients with syncope frequently undergo extensive, low-yield testing (e.g., head CT, broad lab panels) that is inconsistent with guideline recommendations, leading to increased healthcare costs. Furthermore, outpatient follow-up rates are often low, limiting continuity of care [25].
Red flags and high-risk features
Although most pediatric syncopal episodes are benign, early identification of red flags is essential to detect the subset of cases that are potentially life-threatening [26].
History-based red flags
Syncope during exercise (mid-exertion).
Syncope while supine.
Absence of prodrome.
Chest pain or palpitations before collapse.
Known congenital or acquired heart disease.
Family history of sudden unexplained death or inherited cardiac conditions.
Neurologic red flags
Post-ictal confusion.
Tongue biting.
Focal or generalized convulsions.
Eye deviation.
Head trauma.
Known epilepsy.
A personal or family history of convulsive disorders should raise suspicion for a neurologic etiology [30–32].
Metabolic and other red flags [27, 28].
Symptoms suggestive of hypoglycemia.
Features of severe anemia.
Features of electrolyte disturbance.
Pregnancy (in adolescents).
Possible intoxication or drug exposure.
Systemic illness or dehydration.
Examination-based red flags
Pathologic cardiac murmurs (e.g., suggesting outflow obstruction).
Signs of heart failure.
Irregular pulse or marked bradycardia.
Abnormal blood pressure (including orthostatic hypotension).
Focal neurologic deficits.
Signs of trauma or secondary injury.
Investigational red flags (electrocardiographic red flags)
Abnormalities on the 12-lead ECG represent critical objective markers of potential arrhythmogenic syncope.
Long QTc interval (Long QT syndrome): Long QTc (> 0.46 s in post-pubertal females, > 0.45 s in males/children),
Short QTc interval: Short QTc (< 0.32 s).
Brugada pattern (Type 1): Coved ST-segment elevation ≥ 2 mm followed by a negative T wave in ≥ 1 right precordial lead).
Pre-excitation (WPW): Short PR interval, delta wave, widened QRS.
Atrioventricular block (Mobitz II or complete heart block).
Sinus node dysfunction (inappropriate bradycardia or pauses).
Ventricular hypertrophy or repolarization abnormalities.
Clinically significant arrhythmias.
Emergency department risk stratification
A structured approach to history-taking, physical examination, and initial investigations is crucial to stratify patients into risk categories that guide subsequent management. A focused history using high-yield questions is essential to avoid missing high-risk cases while minimizing unnecessary testing.
High-yield history checklist
Pre-Attack (The 3 Ps):
Position: Was the child standing, sitting, or lying down? Was there a recent change in posture? Was the patient asleep/was there an alarm clock or phone ringing, was the patient swimming?
Prodrome: Were there warning symptoms (lightheadedness, nausea, warmth, diaphoresis, sense of increased OR decreased heart rate, early beats, visual changes (blurry vision, dark vision, or tunnel vision), auditory changes (buzzing, ringing, roaring, or muffled hearing).
Provoking Factors: Was the event triggered by pain, emotional stress, prolonged standing, heat, or dehydration, skipping meals, high free water/salt intake, venipuncture and sight of blood?
During Attack (Witness Account):
Onset: Was it sudden or gradual?
Duration: How long did the loss of consciousness last?
Appearance: Was the fall flaccid or stiff? Was the patient awake/could the patient see/hear but not move? Were there any movements (e.g., jerking)? Was there tongue biting or incontinence?
Post-Attack:
Recovery: How long did it take to return to normal? Was there confusion or drowsiness (post-ictal state)?
Residual Symptoms: Was there persistent pallor, nausea, or headache?
Based on this information and initial findings, patients can be categorized using a risk stratification tool, as detailed in Table 2.
Table 2.
Risk stratification tool: red flag checklist with corresponding tier classification and recommended disposition
| Risk | Attack Features | History: | Examination & ECG | |||
|---|---|---|---|---|---|---|
| High Risk |
• Pre-attack: Absence of prodrome, Syncope during exertion, Syncope triggered by a loud noise • During Attack: Sudden onset of the attack, Tonic-clonic movements/following a motor activity |
• Past History: Arrhythmia, structural heart disease, cardiac catheterization, Seizures • Family History: Sudden death, Arrhythmias |
• Physical Examination: Pathologic murmur, Persistent neurologic deficits • ECG findings: long QTc, Brugada pattern, WPW |
|||
| Management: Recommend Urgent Referral to Syncope Specialist or Pediatric Cardiologist | ||||||
| Intermediate Risk |
• Pre-attack: Short or atypical prodrome, Acute chest pain/ Palpitations, Lying supine • During Attack: Duration > 5 min, Exaggerated or flailing movements |
• Past History: Diabetes, Psychiatric disorder or medications, Significant comorbidities, Recurrent, unexplained episodes • Family History: Seizures, Structural heart disease |
• Physical Examination: No significant finding • ECG findings: Borderline or minor ECG abnormalities |
|||
| Management: Consider Further Investigations or Semi-urgent Referral to Syncope Specialist | ||||||
| Low Risk | • Pre-attack: Prodrome (Warmth, nausea, light-headedness, a visual grey-out or tunneling of vision), Post exertional syncope/Prolonged standing/ after postural change, Missed meals, dehydration, Provocative conditions (Painful stimulus, sight of blood, very warm or crowded environment)• During Attack: Short; < 1–2 min• Post Attack: Rapid Recovery | • Past History: No relevant medical history, Typical vasovagal history• Family History: Vasovagal syncope, Migraines | • Physical Examination: Normal• ECG Findings: Normal | |||
| Management: Reassurance, no further investigations needed | ||||||
Diagnostic approach
The diagnostic approach begins with a comprehensive history and physical examination—including orthostatic vital signs, medication review, family history of sudden cardiac death, and detailed characterization of the syncopal event (triggers, prodrome, posture, and recovery)—performed prior to or in parallel with the initial ECG. This step represents the cornerstone of syncope evaluation and enables early identification of high-risk features and appropriate triage pathways, as emphasized in contemporary guideline-based approaches [20–22, 24].
The ECG is the first diagnostic test in all pediatric syncope. No child should be dispositioned without a documented ECG review. The ED physician must interpret and document the 12-lead ECG before disposition, with a pediatric cardiologist over-read within 24–48 h. A standardized recall system should ensure families are promptly contacted if concerning findings arise. High parasternal leads (V1–V2) may be used selectively when Brugada syndrome is suspected, also the long QTc interval must manually verified, as automated algorithms often overestimate QT, especially with U waves [4, 22, 28].
If POTS is suspected (syncope with chronic orthostatic symptoms), perform a standardized 10-minute standing test: after 5 min supine rest with baseline HR/BP, the patient stands while HR and BP are recorded every minute for 10 min, in a quiet setting with minimal movement and no leaning [33–35].
Following this initial assessment, patients are categorized into “presumptive diagnosis,” “suggestive diagnosis,” and “unclassified,” which should be clarified as transitional diagnostic states reflecting the degree of diagnostic certainty rather than formal risk categories, consistent with contemporary risk-stratification frameworks [6, 22, 34].
The “presumptive diagnosis” group includes patients with clinically evident benign etiologies - most commonly reflex syncope, postural orthostatic tachycardia syndrome, or orthostatic hypotension - which can often be diagnosed based on history and examination alone [9, 10, 13]. The “suggestive diagnosis” category includes cases with features concerning for cardiac pathology, prompting further evaluation with echocardiography and ambulatory rhythm monitoring to establish a definitive diagnosis [2, 21, 36]. The “unclassified” group comprises patients with inconclusive initial evaluation, requiring additional targeted testing for less common metabolic, neurological, or psychogenic causes [18, 19, 23].
Laboratory testing should be limited to glucose and pregnancy testing, with additional studies ordered only when clinically indicated. Routine imaging, including chest X-ray and head CT, is not part of standard syncope evaluation [35, 37].
Targeted laboratory testing is recommended over broad panels. A point-of-care blood glucose measurement is essential to rule out hypoglycemia, which can mimic syncope [18]. A pregnancy test is required for all adolescent females due to the physiological changes of pregnancy that can precipitate syncope [37]. Other labs, such as a complete blood count (CBC) to check for anemia or a metabolic panel for electrolyte disturbances, or urine drug/toxins screen should be ordered selectively based on clinical suspicion [38, 39].
More selective testing is reserved for intermediate- or high-risk patients. Point-of-care ultrasound (POCUS) may be considered conditionally at the bedside to assess for gross structural abnormalities like significant pericardial effusion or severe left ventricular dysfunction, but it is not a routine part of the initial workup [5, 40]. For patients with high-risk features or abnormal ECGs, continuous telemetry monitoring is required [18]. Ambulatory monitors like a Holter monitor (24–48 h) or a Zio patch (up to 14 days), or event monitors/recorders worn for up to 30 days are useful for diagnosing intermittent arrhythmias in patients with recurrent, unexplained episodes [35, 36].
The diagnostic algorithm (Fig. 2) should follow a risk-based sequence. For low-risk patients with a normal ECG and clear vasovagal history, the disposition is typically discharge with education. For intermediate-risk patients (e.g., recurrent episodes, atypical features), further testing like ambulatory monitoring and specialist referral is appropriate. For high-risk patients (e.g., abnormal ECG, exertional syncope), the disposition is admission for inpatient monitoring and urgent specialist consultation. Neurological red flags warrant an EEG and neurology referral to differentiate syncope from seizure [18]. Finally, the algorithm emphasizes iterative reassessment and selective referral, ensuring a dynamic, resource-conscious approach that optimizes diagnostic yield while avoiding unnecessary investigations [24, 26–28].
Fig. 2.
Diagnostic algorithm flowchart: from initial presentation through risk stratification to final disposition. ECG = electrocardiogram; SS= situational syncope; POTS = postural orthostatic tachycardia syndrome; OH= orthostatic hypotension; OHT = orthostatic hypertension; CHD = congenital heart disease; VVS = vasovagal syncope
ED Syncope Algorithm:
Risk tier → Targeted test → Disposition.
Low risk → ECG only → Discharge.
Intermediate risk → ECG ± ambulatory monitor → Expedited outpatient follow-up.
High risk → ECG + telemetry + echocardiography → Admission.
Common final diagnoses
Analysis of pediatric syncope presentations to the ED consistently demonstrates that reflex and orthostatic etiologies predominate. Vasovagal syncope is the most frequent diagnosis, accounting for 52.5% to 74% of cases, followed by postural orthostatic tachycardia syndrome (POTS) at approximately 13.1% [27, 41, 42]. In contrast, serious etiologies are uncommon, with cardiac causes identified in ~ 4% and neurological causes (primarily seizures) in ~ 3.1% of cases [27].
Benign etiologies (Reflex and orthostatic causes)
Vasovagal syncope and POTS are the most common final diagnoses and are considered benign. In multiple retrospective studies, VVS was the leading cause, identified in over 70% of patients in some cohorts [41, 42]. Although these conditions are not life-threatening, they can cause significant disruption to a child’s life. A quality improvement initiative suggested that for these low-risk patients, adequate history gathering, physical exam, and a baseline ECG are sufficient for diagnosis, and extensive, costly testing does not improve patient outcomes [43].
Serious etiologies (Cardiac and neurological causes)
Although rare, serious causes corresponding to the high-risk categories are rare but clinically critical to identify. Cardiac causes account for approximately 4% of cases, with arrhythmias representing the most common subtype (16.9% of cardiac cases), while inherited channelopathies (e.g., long QT syndrome) and cardiomyopathies are considerably less frequent (3.4% and < 2%, respectively) [27]. Patients with clinical features suggestive of cardiac syncope (as defined by red flags in Sect. Gaps in current practice) require urgent cardiology evaluation, often including hospital admission for continuous monitoring and consideration of advanced therapies (e.g., ablation or device implantation). Conversely, patients with isolated concerning family history but otherwise normal ED evaluation may be safely managed with expedited outpatient cardiology follow-up within 48–72 h, following direct specialist consultation [27]. Neurological etiologies, primarily seizures misclassified as syncope, account for approximately 3.1% of cases. Other rare but important diagnoses—including anemia, trauma, and intracranial hemorrhage—each contribute to less than 1% of presentations [27].
Disposition framework
Current recommendations for addressing pediatric syncope are consensus-based, meaning timelines are derived from clinical convention rather than evidence-based trials [33]. Therefore, careful risk stratification is needed for assessing syncope severity and determining disposition, such as identifying which cases may be managed as an outpatient versus those that require inpatient observation. The disposition decision should be directly linked to the risk tier identified during the initial evaluation.
Low-risk tier disposition
Patients with diagnoses such as vasovagal syncope and POTS are generally classified as low-risk typically safe for ED discharge, they frequently require acute symptom management with parenteral saline in the ED. Furthermore, discharge planning must include comprehensive education on managing their wide array of systemic symptoms (beyond just presyncope) focusing on trigger avoidance, recognition of presyncope symptoms, and counter-pressure maneuvers. Maintaining adequate oral hydration and increasing salt intake has been shown to be an imperative and effective step in treatment, significantly reducing recurrence rates and a direct referral to a specialist or clinic familiar with the multidisciplinary care of POTS [33–35].
Intermediate-risk tier disposition
Disposition for intermediate-risk cases requires systematic evaluation. Observation or admission may be considered if the clinical presentation suggests a strong likelihood of early complications. Otherwise, patients may be discharged with structured follow-up visits, generally within 1–2 weeks, to a specialized syncope clinic or an appropriate specialist (e.g., neurology for suspected seizures, cardiology for recurrent episodes without clear red flags) [33, 34].
High-risk tier disposition
Children who fall into the high-risk tier, such as those with exertional syncope, abnormal ECG findings, or a concerning family history, warrant hospital admission for further targeted testing, continuous monitoring, and urgent cardiology or neurology evaluation [33, 44]. This approach ensures that patients with potentially life-threatening conditions receive prompt and comprehensive inpatient management.
Research agenda
Future research should prioritize the large-scale validation of pediatric syncope clinical decision rules. Current guidelines are largely consensus-based, and there is limited evidence that existing rules can be reliably generalized to safely identify low-risk children for discharge while accurately detecting dangerous etiologies [34]. Prospective studies are needed to substantiate the role of emerging technologies like POCUS in refining risk stratification at the bedside [45]. Given the diverse causes of pediatric syncope, routine testing in low-risk patients is costly and low-yield. Therefore, future studies should focus on the cost-effectiveness of targeted, minimalist diagnostic algorithms that prioritize safety and resource stewardship by forgoing unnecessary laboratory investigations, imaging, and admissions in low-risk patients.
Conclusion
Pediatric syncope must be managed as an emergency-department safety problem. A risk-stratified, ECG-first pathway ensures that children with cardiac or neurologic disease are rapidly identified and admitted while benign cases are safely discharged. Emergency departments should implement standardized syncope pathways based on red flags, ECG findings, and disposition tiers to reduce missed diagnoses and unnecessary hospitalizations.
Acknowledgements
Not applicable.
Abbreviations
- AHA
American Heart Association
- ACC
American College of Cardiology
- CBC
Complete Blood Count
- CMP
Complete Metabolic Panel
- CHD
Congenital Heart Disease
- ECG
Electrocardiogram (12-lead)
- EEG
Electroencephalogram
- ED
Emergency Department
- EHRA
European Heart Rhythm Association
- EPS
Electrophysiologist
- ESC
European Society of Cardiology
- LOC
Loss of Consciousness
- MRI
Magnetic Resonance Imaging
- NICE
National Institute for Health and Care Excellence
- OH
Orthostatic Hypotension
- OHT
Orthostatic Hypertension
- POTS
Postural Orthostatic Tachycardia Syndrome
- POCUS
Point-Of-Care Ultrasound
- QTc
Corrected QT Interval on ECG
- SS
Situational Syncope
- TLOC
Transient Loss of Consciousness
- VVS
Vasovagal Syncope
- WPW
Wolff-Parkinson-White Syndrome
Author contributions
Khaled Abouelmagd served as the lead author, taking primary responsibility for study design, data acquisition, drafting the initial manuscript, coordinating the project, and facilitating communication among co-authors. Mariam Mohamed Mousa, Sohaila Mohamed Mohamed Abdelbar, Gabriela Berger, Sara Nalli, Alaa Mahmoud Zawrah, and Kisa Fatima contributed to data gathering, interpretation, and the drafting and revision of specific sections of the manuscript. Mohammed Alsabri acted as the senior and corresponding author, conceptualized the research idea, oversaw the project, participated in manuscript drafting, and provided critical revisions to ensure the final version met high intellectual and scientific standards. All authors reviewed and approved the final manuscript and accepted responsibility for the integrity and accuracy of the work.
Funding
Not applicable.
Data availability
All data generated or analyzed during this study are included in this published article.
Declarations
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All authors have approved the manuscript and agree with its submission and publication to the journal.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Epping H, Müller-Schilling M, Dirrigl G, Rockmann F, Brünnler T. Syncope diagnostics in the emergency department – significance of the ESC guidelines. Med Klin Intensivmed Notfmed. 2025;15:1–7. [DOI] [PubMed]
- 2.Ritter S, Tani LY, Etheridge SP, Williams RV, Craig JE, Minich LL. What is the yield of screening echocardiography in pediatric syncope? Pediatrics. 2000;105(5):E58. [DOI] [PubMed] [Google Scholar]
- 3.Linzer M, Pontinen M, Gold DT, Divine GW, Felder A. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44(10):1037–43. [DOI] [PubMed] [Google Scholar]
- 4.Manouzi A, Sanatani S, Doan Q. Electrocardiogram in pediatric syncope: practice variation among pediatric emergency physicians. Pediatr Emerg Care. 2022;38(2):e886–90. [DOI] [PubMed] [Google Scholar]
- 5.Scheier E. Cardiac POCUS in pediatric emergency medicine: a narrative review. J Clin Med. 2023;12(17):5666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Thiruganasambandamoorthy V, Sivilotti ML, Le Sage N, Yan JW, Huang P, Hegdekar M, et al. Multicenter emergency department validation of the Canadian syncope risk score. JAMA Intern Med. 2020;180(5):737–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Colman N, Nahm K, Ganzeboom KS, et al. Epidemiology of reflex syncope. Clin Auton Res. 2004;14(Suppl 1):9–17. [DOI] [PubMed] [Google Scholar]
- 8.Bhalla R, Soobhanath C, Celebi S, Chhabra M et al. Unusual Cases of Syncope in the Pediatric Age Group. 2021. Available from: ncbi.nlm.nih.gov. [DOI] [PMC free article] [PubMed]
- 9.Stewart JM. Common syndromes of orthostatic intolerance. Pediatrics. 2013;131(5):968–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Benditt DG, Nguyen JT. Vasovagal syncope: a common, benign condition. Circulation. 2009;120(18):1763–5. [Google Scholar]
- 11.Jardine DL, Wieling W, Brignole M, et al. The pathophysiology of the vasovagal response. Heart Rhythm. 2018;15(6):921–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–24. [DOI] [PubMed] [Google Scholar]
- 13.Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Stephenson JB. Reflex anoxic seizures (‘white breath-holding’): nonepileptic vagal attacks. Arch Dis Child. 1978;53(3):193–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Friedman KG, Alexander ME. Chest pain and syncope in children: a practical approach. Pediatrics. 2013;131(5):e1530–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sheldon R, Rose S, Ritchie D, Connolly S, Koshman ML, Frenneaux M. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40(1):142–8. [DOI] [PubMed] [Google Scholar]
- 18.Wester M, Bergmann T, Müller-Schilling M, Maier LS, Sossalla ST. Transient hypoglycemia as a rare cause of recurring transient loss of consciousness: a case report. J Med Case Rep. 2021;15(1):261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gracie J, Newton JL. Psychogenic pseudosyncope: diagnosis and management. Auton Neurosci. 2014;184:66–72. [DOI] [PubMed] [Google Scholar]
- 20.Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Krahn AD, Link MS, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary. Circulation. 2017;136:e25–59. [DOI] [PubMed] [Google Scholar]
- 21.Schunk PC, Ruttan T. Pediatric syncope approach. Emerg Med Clin North Am. 2018;36(2):349–65. [DOI] [PubMed] [Google Scholar]
- 22.Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883–948. [DOI] [PubMed] [Google Scholar]
- 23.National Institute for Health and Care Excellence (NICE). Suspected neurological conditions: recognition and referral. NICE guideline [NG127]. London: NICE; 2023. [PubMed] [Google Scholar]
- 24.Fant C, Cohen A. Syncope In Pediatric Patients: A Practical Approach To Differential Diagnosis And Management In The Emergency Department. Pediatr Emerg Med Pract. 2017;14(4):1–28. [PubMed] [Google Scholar]
- 25.Conner TM, Tamirisa S, Roelle LM, Miller N, Pompa A, Orr WB, et al. Assessment of current pediatric electrocardiogram (ECG) interpretation practices. Prog Pediatr Cardiol. 2024;74:101738. [Google Scholar]
- 26.Redd C, Thomas C, Willis M, Amos M, Anderson J. Cost of unnecessary testing in the evaluation of pediatric syncope. Pediatr Cardiol. 2017;38(6):1115–22. [DOI] [PubMed] [Google Scholar]
- 27.Zavala R, Metais B, Tuckfield L, DelVecchio M, Aronoff S. Pediatric Syncope: A Systematic Review. Pediatr Emerg Care. 2020;36(9):442–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sanatani S, Chau V, Fournier A, Dixon A, Blondin R, Sheldon RS. Canadian Cardiovascular Society and Canadian Pediatric Cardiology Association Position Statement on the Approach to Syncope in the Pediatric Patient. Can J Cardiol. 2017;33(2):189–98. [DOI] [PubMed] [Google Scholar]
- 29.Gilpin K, Goode Z, Syncope. Pediatr Rev. 2024;45(10):606–8. [DOI] [PubMed] [Google Scholar]
- 30.Johns Hopkins All Children’s Hospital. Syncope clinical pathway. Updated September 2021. [Internet]. Johns Hopkins Medicine. 2021. Available from: https://www.hopkinsmedicine.org/-/media/files/allchildrens/clinical-pathways/syncope-pathway-10-6-21.pdf
- 31.Cannon B, Wackel P, Syncope. Pediatr Rev. 2016;37(4):159–68. [DOI] [PubMed] [Google Scholar]
- 32.Franjić S. Syncope in Children. J Pediatr Neonatal Biol. 2022;7.
- 33.Singhi P, Saini AG. Syncope in Pediatric Practice. Indian J Pediatr. 2018;85:636–40. [DOI] [PubMed] [Google Scholar]
- 34.Sutton R, Ricci F, Fedorowski A. Risk stratification of syncope: Current syncope guidelines and beyond. Auton Neurosci. 2022;238:102929. [DOI] [PubMed] [Google Scholar]
- 35.Wang C, Liao Y, Wang S, Tian H, Huang M, Dong XY, et al. Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (Revised 2024). World J Pediatr. 2024;20(10):983–1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pradhan S, Robinson JA, Shivapour JK, Snyder CS. Ambulatory arrhythmia detection with zio® xt patch in pediatric patients: a comparison of devices. Pediatr Cardiol. 2019;40(5):921–4. [DOI] [PubMed] [Google Scholar]
- 37.Zhu W, Bian X, Lv J. Advances in diagnosis, management, and long-term outcomes of pediatric vasovagal syncope: a comprehensive review. Front Cardiovasc Med. 2025;12:1481749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Javier RC, Singh PV, Shrestha J, Abdalla R, Narang P, Patel H, et al. Trends and immediate outcomes of syncope during pregnancy: a narrative review. Cureus. 2023;15(12):e49833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hatharasinghe AT, Etebar K, Wolsky R, Akhondi H, Ayutyanont N. An assessment of the diagnostic value in syncope workup: a retrospective study. HCA Healthc J Med. 2021;2(6):423–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Johri AM, Glass C, Hill B, Jensen T, Puentes W, Olusanya O, et al. The evolution of cardiovascular ultrasound: a review of cardiac point-of-care ultrasound (Pocus) across specialties. Am J Med. 2023;136(7):621–8. [DOI] [PubMed] [Google Scholar]
- 41.Libdeh AA, Al-Ammouri I, Otoom G, Chabaan R, Tutunji L, Phillips LH 2, et al. Pediatric syncope in specialty clinics: clinical characteristics and lessons learned. Int J Pediatr Adolesc Med. 2025;12(4):179–83. [Google Scholar]
- 42.Shenk MER, Anilkumar A. Syncope in children: etiology, positive and negative predictors, and utilization and utility of diagnostic testing (P3.204). Neurology. 2017;88(16 Suppl):P3204. [Google Scholar]
- 43.Winder MM, Marietta J, Kerr LM, Puchalski MD, Zhang C, Ware AL, et al. Reducing unnecessary diagnostic testing in pediatric syncope: a quality improvement initiative. Pediatr Cardiol. 2021;42(4):942–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Wang Y, Wang Y, Li X, Du J, Zhang H, Jin H, et al. Efficacy of increased salt and water intake on pediatric vasovagal syncope: a meta-analysis based on global published data. Front Pediatr. 2021;9:663016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lin-Martore M, Kornblith A, Firnberg M, Haque A, O’Brien B. Trust of artificial intelligence-augmented point-of-care ultrasound among pediatric emergency medicine physicians. J Am Coll Emerg Physicians Open. 2025;6(4):100173. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analyzed during this study are included in this published article.


